Monogram Orthopaedics Inc. Common Stock Cash Flow-to-Debt Ratio
Monogram Orthopaedics Inc. Common Stock cash flow-to-debt ratio. Monogram Orthopaedics Inc. Common Stock (MGRM) has a Cash Flow-to-Debt Ratio of -0.36x as of June 2025, meaning its operating cash flow of $-2.30 Million could theoretically repay 0% of its total liabilities ($6.38 Million) in one year. See Monogram Orthopaedics Inc. Common Stock (MGRM) flexibility index to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Cash Flow-to-Debt Ratio of Monogram Orthopaedics Inc. Common Stock (2017–2024)
Cash flow-to-debt ratio of Monogram Orthopaedics Inc. Common Stock from 2017 to 2024. Historical debt coverage capacity for Monogram Orthopaedics Inc. Common Stock across 8 annual periods. Also explore MGRM year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Monogram Orthopaedics Inc. Common Stock Cash Flow-to-Debt Ratio by Year (2017–2024)
Monogram Orthopaedics Inc. Common Stock cash flow-to-debt ratio by year from 2017 to 2024. Year-by-year debt coverage analysis for Monogram Orthopaedics Inc. Common Stock. For the full cash flow conversion analysis, see Monogram Orthopaedics Inc. Common Stock operating cash flow efficiency.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -4.28x | $-13.97 Million | $3.27 Million | ▼ -0.5% |
| 2023 | -4.26x | $-13.54 Million | $3.18 Million | ▼ -382.3% |
| 2022 | -0.88x | $-8.42 Million | $9.54 Million | ▲ +49.8% |
| 2021 | -1.76x | $-9.17 Million | $5.21 Million | ▼ -1.8% |
| 2020 | -1.73x | $-5.40 Million | $3.13 Million | ▼ -377.3% |
| 2019 | -0.36x | $-1.05 Million | $2.89 Million | ▼ -203.9% |
| 2018 | -0.12x | $-306.87K | $2.58 Million | ▲ +79.8% |
| 2017 | -0.59x | $-619.37K | $1.05 Million | — |